WilmerHale Counsels Suono Bio in Seed Funding Led by Polaris and MIT’s The Engine

WilmerHale Counsels Suono Bio in Seed Funding Led by Polaris and MIT’s The Engine

Firm News

Suono Bio, a company developing a platform technology designed to enable ultra-rapid delivery of therapeutics—including proteins and nucleic acids—to the gastrointestinal tract, has announced that it has raised its seed funding round from Polaris, MIT's “The Engine” and other investors. The seed round will go toward getting the technology prepped for human trials.

The WilmerHale team counseling Suono Bio was led by Joshua Fox and included Stephanie Singer and Hilary Baker-Jennings.

Read "A company that wants to use ultrasounds to deliver drugs just raised money from MIT's new $200 million venture fund," published by Business Insider to learn more.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.